Condition 1: Blood pressure. Condition 2: Heart beat. Examination of blood pressure Abnormalities of heart beat
Conditions
Interventions
Intervention 1: For the intervention group 1.8 mL cartridges containing 20 mg lidocaine hydrochloride 2% with 12.5 micrograms epinephrine 1/80000 with brand name of persocaine made by Daroopakhsh Manu
Prevention
Treatment - Drugs
For the intervention group 1.8 mL cartridges containing 20 mg lidocaine hydrochloride 2% with 12.5 micrograms epinephrine 1/80000 with brand name of persocaine made by Daroopakhsh Manufacturing Co. wi
For patients in the control group, the same volume of lidocaine hydrochloride 2% (100 mg per 5 ml) made by daroopakhsh Co. will be injected
Sponsors
Vice chancellor for research of Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
17 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age 18 to 45 years; refering for removal of permanent teeth. Exclusion criteria: cardiovascular disease; asthma; hyperthyroidism; receiving antihypertensive, antidepressants and anti-anxiety drugs; sensitivity to lidocaine
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Systolic blood pressure. Timepoint: Before injection of anesthetic, 15 minutes after the injection of local anesthesia and 10 minutes after the end of surgery. Method of measurement: mmHg.;Diastolic blood pressure. Timepoint: Before injection of anesthetic, 15 minutes after the injection of local anesthesia and 10 minutes after the end of surgery. Method of measurement: mmHg.;Heart rate. Timepoint: Before injection of anesthetic, 15 minutes after the injection of local anesthesia and 10 minutes after the end of surgery. Method of measurement: Number per minute. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmirhossein Pakravan
Mazandaran University of Medical Sciences
Outcome results
None listed